Abstract
Isolated from Hypericum species H. chinese L. var. salicifolium, biyouyanagin A was assigned structure 1a or 1b on the basis of NMR spectroscopic analysis. This novel natural product exhibited significant anti-HIV properties and inhibition of lipopolysaccharide-induced cytokine production. Described herein are the total syntheses of biyouyanagin A and several analogues (3-11), structural revision of biyouyanagin A to 2b, and the biological properties of all synthesized compounds. The total synthesis proceeded through cascade sequences that efficiently produced enantiomerically pure key building blocks 15b (ent-zingiberene) and 18 (hyperolactone C) and featured a novel [2 + 2] photoinduced cycloaddition reaction which occurred with complete regio- and stereoselectivity. Biological investigations with the synthesized biyouyangagins A (2-11) and hyperolactones C (12-16) revealed that the activity of biyouyanagin A most likely resides in its hyperolactone C structural domain.
Publication types
-
Research Support, N.I.H., Extramural
-
Research Support, Non-U.S. Gov't
MeSH terms
-
Anti-HIV Agents / chemical synthesis*
-
Anti-HIV Agents / chemistry
-
Anti-HIV Agents / pharmacology
-
Cell Line
-
Cell Proliferation / drug effects
-
Crystallography, X-Ray
-
Cytokines / biosynthesis
-
Cytokines / drug effects
-
Drug Evaluation, Preclinical
-
Furans / chemical synthesis
-
Furans / chemistry
-
Furans / pharmacology
-
HIV / drug effects
-
Humans
-
Hypericum / chemistry
-
Inhibitory Concentration 50
-
Lipopolysaccharides / antagonists & inhibitors
-
Lipopolysaccharides / pharmacology
-
Lymphocytes / drug effects
-
Magnetic Resonance Spectroscopy / methods
-
Microbial Sensitivity Tests
-
Models, Molecular
-
Molecular Conformation
-
Sensitivity and Specificity
-
Sesquiterpenes / chemical synthesis*
-
Sesquiterpenes / chemistry
-
Sesquiterpenes / pharmacology
-
Spiro Compounds
-
Stereoisomerism
Substances
-
Anti-HIV Agents
-
Cytokines
-
Furans
-
Lipopolysaccharides
-
Sesquiterpenes
-
Spiro Compounds
-
biyouyanagin A
-
hyperolactone C